High-risk interaction triage
Dofetilide with trimethoprim: monitoring does not remove the contraindication
A urinary antibiotic can create an arrhythmia risk through a medicine interaction. Dofetilide labeling contraindicates trimethoprim both alone and in combination with sulfamethoxazole; a planned ECG is not permission to use the pair.
Sources checked October 12, 2026. Independent educational content, not NABP exam questions or individual treatment advice.
Check both ingredients of the antibiotic
The dofetilide contraindication names trimethoprim alone and trimethoprim with sulfamethoxazole. The combination may appear as Bactrim, TMP-SMX or co-trimoxazole in a medication list. Recognizing only a brand can miss the active ingredient.
The antibiotic indication does not cancel the contraindication. A common urinary infection prescription still requires a complete interaction check before dispensing.
Distinguish the exposure interaction from a generic QT alert
Dofetilide blocks the rapid delayed rectifier potassium current and can cause QT prolongation and torsades de pointes. Trimethoprim inhibits its renal cation transport pathway, increasing dofetilide plasma concentrations.
This is not only a question of whether the antibiotic is remembered as a QT-prolonging drug. An exposure interaction can make the antiarrhythmic more hazardous. Use the named contraindication rather than a generic class-based shortcut.
Do not treat an ECG as a workaround
The label contraindicates the combination. A normal previous QTc, a reduced antibiotic dose or an extra planned ECG does not establish a supported exception. The clinical team should select an appropriate infection-treatment plan.
The label also describes renal and QT monitoring for dofetilide itself. Those safeguards are important but do not turn every prohibited interacting medicine into an acceptable addition.
Keep chronic therapy and antibiotic selection connected
Do not tell the patient to abruptly omit dofetilide merely to make room for an antibiotic. Initiation and re-initiation have monitored-setting requirements, and a treatment interruption is not a casual substitution strategy.
An exam answer should identify the contraindicated ingredient and the reason for escalation. A real replacement antibiotic depends on culture, infection site, allergies and other patient facts, not only the desire to remove one interaction.
A worked case
A patient on dofetilide is prescribed trimethoprim-sulfamethoxazole for a urinary infection. Their last ECG was normal. A draft approves the pair with a repeat ECG in a week. Why is that not an adequate answer?
- The trimethoprim ingredient is explicitly contraindicated with dofetilide.
- The interaction increases dofetilide exposure and arrhythmia risk.
- A prior normal ECG does not provide an exception; the antibiotic plan needs clinical review.
Answer: Do not approve the contraindicated combination on the basis of added monitoring. Resolve an appropriate treatment plan with the prescriber.
Try it before reading the answer
Write the key fact, decision and safety check first. These are original practice exercises, not recalled exam items.
1. Is trimethoprim alone also included?
Yes.
2. Does a prior normal ECG remove the contraindication?
No.
3. Should the patient casually stop dofetilide to take the antibiotic?
No. The clinical team must manage both treatment plans.
Continue learning
Put the topic into a study planSources and scope
Source dates and limits matter. Follow the current official source for clinical or regulatory decisions. Examples are simplified teaching cases, not prescribing, diagnostic or compounding instructions. Check the full current guidance and individual clinical context.